180 related articles for article (PubMed ID: 12790780)
1. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.
Doisneau-Sixou SF; Sergio CM; Carroll JS; Hui R; Musgrove EA; Sutherland RL
Endocr Relat Cancer; 2003 Jun; 10(2):179-86. PubMed ID: 12790780
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
3. Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC.
Kolli S; Buchmann AM; Williams J; Weitzman S; Thimmapaya B
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4646-51. PubMed ID: 11296295
[TBL] [Abstract][Full Text] [Related]
4. Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic).
Ronchini C; Capobianco AJ
Mol Cell Biol; 2001 Sep; 21(17):5925-34. PubMed ID: 11486031
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus type 2 increases proteosome-dependent degradation of p21WAF1 in a human papillomavirus type 31b-positive cervical carcinoma line.
Alam S; Sen E; Brashear H; Meyers C
J Virol; 2006 May; 80(10):4927-39. PubMed ID: 16641284
[TBL] [Abstract][Full Text] [Related]
6. IL-4 inhibits cell cycle progression of human umbilical vein endothelial cells by affecting p53, p21(Waf1), cyclin D1, and cyclin E expression.
Kim J; Cheon IS; Won YJ; Na HJ; Kim YM; Choe J
Mol Cells; 2003 Aug; 16(1):92-6. PubMed ID: 14503851
[TBL] [Abstract][Full Text] [Related]
7. Cells use multiple mechanisms for cell-cycle arrest upon withdrawal of individual amino acids.
Rong Y; Darnell AM; Sapp KM; Vander Heiden MG; Spencer SL
Cell Rep; 2023 Dec; 42(12):113539. PubMed ID: 38070134
[TBL] [Abstract][Full Text] [Related]
8. Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells.
Junk DJ; Cipriano R; Stampfer M; Jackson MW
PLoS One; 2013; 8(2):e53776. PubMed ID: 23390492
[TBL] [Abstract][Full Text] [Related]
9. Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry.
Darzynkiewicz Z; Zhao H; Zhang S; Lee MY; Lee EY; Zhang Z
Oncotarget; 2015 May; 6(14):11735-50. PubMed ID: 26059433
[TBL] [Abstract][Full Text] [Related]
10. CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution?
Manousakis E; Miralles CM; Esquerda MG; Wright RHG
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139316
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species-mediated cyclin D1 degradation mediates tumor growth retardation in hypoxia, independently of p21cip1 and hypoxia-inducible factor.
Lim JH; Lee YM; Chun YS; Park JW
Cancer Sci; 2008 Sep; 99(9):1798-805. PubMed ID: 18616527
[TBL] [Abstract][Full Text] [Related]
12. Effects of tachyplesin on the regulation of cell cycle in human hepatocarcinoma SMMC-7721 cells.
Li QF; Ou-Yang GL; Peng XX; Hong SG
World J Gastroenterol; 2003 Mar; 9(3):454-8. PubMed ID: 12632496
[TBL] [Abstract][Full Text] [Related]
13. Anti-leukaemic effects of two extract types of Lactuca sativa correlate with the activation of Chk2, induction of p21, downregulation of cyclin D1 and acetylation of alpha-tubulin.
Gridling M; Popescu R; Kopp B; Wagner KH; Krenn L; Krupitza G
Oncol Rep; 2010 Apr; 23(4):1145-51. PubMed ID: 20204303
[TBL] [Abstract][Full Text] [Related]
14. A map of protein dynamics during cell-cycle progression and cell-cycle exit.
Gookin S; Min M; Phadke H; Chung M; Moser J; Miller I; Carter D; Spencer SL
PLoS Biol; 2017 Sep; 15(9):e2003268. PubMed ID: 28892491
[TBL] [Abstract][Full Text] [Related]
15. CDK8: a new breast cancer target.
Crown J
Oncotarget; 2017 Feb; 8(9):14269-14270. PubMed ID: 28209918
[No Abstract] [Full Text] [Related]
16. Acute-on-Chronic Liver Failure Incited by Cyclin-Dependent Kinase Inhibitor Therapy for Breast Cancer Effectively Treated With Liver Transplantation.
Kalas V; Nguyen J; Wan AW; Dietch ZC; Kulik L; Hughes DL
ACG Case Rep J; 2024 Jan; 11(1):e01253. PubMed ID: 38274302
[TBL] [Abstract][Full Text] [Related]
17. Correction: ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells.
Li S; Xue J; Zhang H; Shang G
J Orthop Surg Res; 2023 Dec; 18(1):972. PubMed ID: 38105224
[No Abstract] [Full Text] [Related]
18. Estrogen regulation of cell cycle progression in breast cancer cells.
Prall OW; Rogan EM; Sutherland RL
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):169-74. PubMed ID: 9699870
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle-dependent expression of estrogen receptor and effect of estrogen on proliferation of synchronized human osteoblast-like osteosarcoma cells.
Ikegami A; Inoue S; Hosoi T; Kaneki M; Mizuno Y; Akedo Y; Ouchi Y; Orimo H
Endocrinology; 1994 Aug; 135(2):782-9. PubMed ID: 8033827
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
Watts CK; Sweeney KJ; Warlters A; Musgrove EA; Sutherland RL
Breast Cancer Res Treat; 1994; 31(1):95-105. PubMed ID: 7981461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
